Artwork

Indhold leveret af BioTech Nation Team and Moira Gunn. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af BioTech Nation Team and Moira Gunn eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
Player FM - Podcast-app
Gå offline med appen Player FM !

FDA Approval! A New Model for BioPharma... Dr. Sam Blackman, Founder & Head of Research and Development, Day One Biopharmaceuticals

31:10
 
Del
 

Manage episode 421961118 series 3360496
Indhold leveret af BioTech Nation Team and Moira Gunn. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af BioTech Nation Team and Moira Gunn eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

This week on BioTech Nation, Dr. Sam Blackman, Founder and Head of Research and Development from Day One Biopharmaceuticals, shares the story behind the FDA approval of a groundbreaking drug for the most common childhood brain cancer. He talks about their innovative approach to starting a biopharma company and how it led to a newly FDA approved drug that treats the most common form of brain cancer in children

  continue reading

99 episoder

Artwork
iconDel
 
Manage episode 421961118 series 3360496
Indhold leveret af BioTech Nation Team and Moira Gunn. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af BioTech Nation Team and Moira Gunn eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

This week on BioTech Nation, Dr. Sam Blackman, Founder and Head of Research and Development from Day One Biopharmaceuticals, shares the story behind the FDA approval of a groundbreaking drug for the most common childhood brain cancer. He talks about their innovative approach to starting a biopharma company and how it led to a newly FDA approved drug that treats the most common form of brain cancer in children

  continue reading

99 episoder

Alle Folgen

×
 
Loading …

Velkommen til Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Hurtig referencevejledning